AQR Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$562K Buy
768,921
+100,956
+15% +$73.8K ﹤0.01% 2555
2025
Q1
$539K Sell
667,965
-546,569
-45% -$441K ﹤0.01% 2389
2024
Q4
$1.68M Sell
1,214,534
-305,177
-20% -$421K ﹤0.01% 1626
2024
Q3
$1.58M Buy
1,519,711
+799,712
+111% +$832K ﹤0.01% 1607
2024
Q2
$1.25M Buy
+719,999
New +$1.25M ﹤0.01% 1654
2024
Q1
Sell
-371,366
Closed -$1.24M 2429
2023
Q4
$1.24M Buy
371,366
+330,233
+803% +$1.1M ﹤0.01% 1526
2023
Q3
$154K Sell
41,133
-2,083
-5% -$7.79K ﹤0.01% 2180
2023
Q2
$185K Sell
43,216
-27,000
-38% -$115K ﹤0.01% 2087
2023
Q1
$480K Sell
70,216
-14,776
-17% -$101K ﹤0.01% 1793
2022
Q4
$673K Buy
84,992
+47,670
+128% +$378K ﹤0.01% 1707
2022
Q3
$359K Sell
37,322
-8,560
-19% -$82.3K ﹤0.01% 1889
2022
Q2
$332K Sell
45,882
-31,826
-41% -$230K ﹤0.01% 1829
2022
Q1
$1M Buy
77,708
+60,442
+350% +$780K ﹤0.01% 1531
2021
Q4
$276K Sell
17,266
-2,564
-13% -$41K ﹤0.01% 2006
2021
Q3
$319K Sell
19,830
-7,177
-27% -$115K ﹤0.01% 2020
2021
Q2
$374K Sell
27,007
-84,533
-76% -$1.17M ﹤0.01% 1984
2021
Q1
$1.63M Buy
111,540
+16,187
+17% +$237K ﹤0.01% 1320
2020
Q4
$1.66M Sell
95,353
-16,945
-15% -$294K ﹤0.01% 1261
2020
Q3
$2.06M Sell
112,298
-107,796
-49% -$1.98M ﹤0.01% 1089
2020
Q2
$3.93M Buy
220,094
+128,672
+141% +$2.3M 0.01% 877
2020
Q1
$1.48M Buy
91,422
+54,237
+146% +$880K ﹤0.01% 1182
2019
Q4
$670K Buy
37,185
+19,254
+107% +$347K ﹤0.01% 1655
2019
Q3
$363K Buy
17,931
+3,567
+25% +$72.2K ﹤0.01% 1856
2019
Q2
$317K Sell
14,364
-8,903
-38% -$196K ﹤0.01% 1864
2019
Q1
$317K Sell
23,267
-16,158
-41% -$220K ﹤0.01% 1949
2018
Q4
$357K Buy
+39,425
New +$357K ﹤0.01% 1897
2017
Q4
Sell
-26,915
Closed -$359K 2226
2017
Q3
$359K Buy
26,915
+13,015
+94% +$174K ﹤0.01% 2035
2017
Q2
$199K Sell
13,900
-3,029
-18% -$43.4K ﹤0.01% 2130
2017
Q1
$358K Buy
+16,929
New +$358K ﹤0.01% 1973